ID   ITK_HUMAN               Reviewed;         620 AA.
AC   Q08881; B2R752; Q32ML7;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   05-OCT-2010, entry version 120.
DE   RecName: Full=Tyrosine-protein kinase ITK/TSK;
DE            EC=2.7.10.2;
DE   AltName: Full=Kinase EMT;
DE   AltName: Full=T-cell-specific kinase;
DE   AltName: Full=Tyrosine-protein kinase Lyk;
GN   Name=ITK; Synonyms=EMT, LYK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=93279365; PubMed=8504851; DOI=10.1016/0014-5793(93)81520-A;
RA   Tanaka N., Asao H., Ohtani K., Nakamura M., Sugamura K.;
RT   "A novel human tyrosine kinase gene inducible in T cells by
RT   interleukin 2.";
RL   FEBS Lett. 324:1-5(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thymus;
RX   MEDLINE=93372354; PubMed=8364206;
RA   Gibson S., Leung B., Squire J.A., Hill M., Arima N., Goss P., Hogg D.,
RA   Mills G.B.;
RT   "Identification, cloning, and characterization of a novel human T-
RT   cell-specific tyrosine kinase located at the hematopoietin complex on
RT   chromosome 5q.";
RL   Blood 82:1561-1572(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 171-192, AND PHOSPHORYLATION AT TYR-180.
RX   PubMed=12573241; DOI=10.1016/S1570-9639(02)00524-1;
RA   Nore B.F., Mattsson P.T., Antonsson P., Backesjo C.-M., Westlund A.,
RA   Lennartsson J., Hansson H., Low P., Ronnstrand L., Smith C.I.E.;
RT   "Identification of phosphorylation sites within the SH3 domains of Tec
RT   family tyrosine kinases.";
RL   Biochim. Biophys. Acta 1645:123-132(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-512 AND SER-565, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-512 AND SER-565, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-296, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   STRUCTURE BY NMR OF 113-239.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the BTK motif and the SH3 domain of tyrosine-
RT   protein kinase ITK from human.";
RL   Submitted (OCT-2007) to the PDB data bank.
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-19; LEU-23; GLN-451; TRP-581 AND
RP   ILE-587.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [12]
RP   VARIANT LPSA1 TRP-335, AND CHARACTERIZATION OF VARIANT LPSA1 TRP-335.
RX   PubMed=19425169; DOI=10.1172/JCI37901;
RA   Huck K., Feyen O., Niehues T., Rueschendorf F., Huebner N.,
RA   Laws H.-J., Telieps T., Knapp S., Wacker H.-H., Meindl A., Jumaa H.,
RA   Borkhardt A.;
RT   "Girls homozygous for an IL-2-inducible T cell kinase mutation that
RT   leads to protein deficiency develop fatal EBV-associated
RT   lymphoproliferation.";
RL   J. Clin. Invest. 119:1350-1358(2009).
CC   -!- FUNCTION: Plays a role in T-cell proliferation and
CC       differentiation.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- COFACTOR: Binds 1 zinc ion per subunit (By similarity).
CC   -!- SUBUNIT: Ligation of CD2, TCR or CD28 induces activation and
CC       tyrosine phosphorylation of ITK. Interacts with THEMIS (By
CC       similarity).
CC   -!- INTERACTION:
CC       P48023:FASLG; NbExp=2; IntAct=EBI-968552, EBI-495538;
CC   -!- SUBCELLULAR LOCATION: Cell membrane (By similarity).
CC       Note=Localizes to cell surface receptors in the plasma membrane
CC       after stimulation with respective receptors (TCR, CD28, CD2) in T-
CC       cells (By similarity).
CC   -!- TISSUE SPECIFICITY: T-cell lines and natural killer cell lines.
CC   -!- INDUCTION: By IL2/interleukin-2.
CC   -!- DISEASE: Defects in ITK are the cause of lymphoproliferative
CC       syndrome EBV-associated autosomal type 1 (LPSA1) [MIM:613011].
CC       LPSA1 is a rare immunodeficiency characterized by extreme
CC       susceptibility to infection with Epstein-Barr virus (EBV).
CC       Inadequate immune response to EBV can have a fatal outcome.
CC       Clinical features include splenomegaly, lymphadenopathy, anemia,
CC       thrombocytopenia, pancytopenia, recurrent infections. There is an
CC       increased risk for lymphoma.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. TEC subfamily.
CC   -!- SIMILARITY: Contains 1 Btk-type zinc finger.
CC   -!- SIMILARITY: Contains 1 PH domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -!- SIMILARITY: Contains 1 SH3 domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ITKID43329ch5q33.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D13720; BAA02873.1; -; mRNA.
DR   EMBL; L10717; AAA36748.1; -; mRNA.
DR   EMBL; S65186; AAB28072.2; -; mRNA.
DR   EMBL; AK312846; BAG35699.1; -; mRNA.
DR   EMBL; CH471062; EAW61608.1; -; Genomic_DNA.
DR   EMBL; BC109077; AAI09078.1; -; mRNA.
DR   EMBL; BC109078; AAI09079.1; -; mRNA.
DR   IPI; IPI00004566; -.
DR   PIR; S33253; S33253.
DR   RefSeq; NP_005537.3; -.
DR   UniGene; Hs.558348; -.
DR   PDB; 1SM2; X-ray; 2.30 A; A/B=357-620.
DR   PDB; 1SNU; X-ray; 2.50 A; A/B=357-620.
DR   PDB; 1SNX; X-ray; 3.20 A; A/B=357-620.
DR   PDB; 2E6I; NMR; -; A=113-169.
DR   PDB; 2YUQ; NMR; -; A=162-239.
DR   PDB; 3MIY; X-ray; 1.67 A; A/B=357-620.
DR   PDB; 3MJ1; X-ray; 1.72 A; A=357-620.
DR   PDB; 3MJ2; X-ray; 1.90 A; A=357-620.
DR   PDBsum; 1SM2; -.
DR   PDBsum; 1SNU; -.
DR   PDBsum; 1SNX; -.
DR   PDBsum; 2E6I; -.
DR   PDBsum; 2YUQ; -.
DR   PDBsum; 3MIY; -.
DR   PDBsum; 3MJ1; -.
DR   PDBsum; 3MJ2; -.
DR   ProteinModelPortal; Q08881; -.
DR   SMR; Q08881; 5-146, 232-339.
DR   DIP; DIP-29974N; -.
DR   IntAct; Q08881; 4.
DR   MINT; MINT-110502; -.
DR   STRING; Q08881; -.
DR   PhosphoSite; Q08881; -.
DR   PeptideAtlas; Q08881; -.
DR   PRIDE; Q08881; -.
DR   Ensembl; ENST00000422843; ENSP00000398655; ENSG00000113263.
DR   GeneID; 3702; -.
DR   KEGG; hsa:3702; -.
DR   UCSC; uc003lwo.1; human.
DR   CTD; 3702; -.
DR   GeneCards; GC05P156607; -.
DR   H-InvDB; HIX0024849; -.
DR   HGNC; HGNC:6171; ITK.
DR   MIM; 186973; gene.
DR   MIM; 613011; phenotype.
DR   PharmGKB; PA29968; -.
DR   eggNOG; prNOG16075; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; Q08881; -.
DR   OMA; HVYQIMN; -.
DR   OrthoDB; EOG92JRBF; -.
DR   PhylomeDB; Q08881; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; pi3kcipathway; Class I PI3K signaling events.
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 14507; -.
DR   ArrayExpress; Q08881; -.
DR   Bgee; Q08881; -.
DR   CleanEx; HS_ITK; -.
DR   Genevestigator; Q08881; -.
DR   GermOnline; ENSG00000113263; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; TAS:ProtInc.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_type.
DR   InterPro; IPR001849; Pleckstrin_homology.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR020697; Tyr_kinase_non-rcpt_ITK/TSK.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR001562; Znf_Btk_motif.
DR   Gene3D; G3DSA:2.30.29.30; PH_type; 1.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   PANTHER; PTHR23256:SF138; Tyr_kinase_non-rcpt_ITK/TSK; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF00779; BTK; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00107; BTK; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50044; SH3; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS51113; ZF_BTK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Kinase; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; SH2 domain; SH3 domain; Transferase;
KW   Tyrosine-protein kinase; Zinc; Zinc-finger.
FT   CHAIN         1    620       Tyrosine-protein kinase ITK/TSK.
FT                                /FTId=PRO_0000088106.
FT   DOMAIN        4    111       PH.
FT   DOMAIN      171    231       SH3.
FT   DOMAIN      239    338       SH2.
FT   DOMAIN      363    615       Protein kinase.
FT   ZN_FING     113    149       Btk-type.
FT   NP_BIND     369    377       ATP (By similarity).
FT   ACT_SITE    482    482       Proton acceptor (By similarity).
FT   METAL       121    121       Zinc (By similarity).
FT   METAL       132    132       Zinc (By similarity).
FT   METAL       133    133       Zinc (By similarity).
FT   METAL       143    143       Zinc (By similarity).
FT   BINDING     391    391       ATP (By similarity).
FT   MOD_RES     180    180       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     296    296       N6-acetyllysine.
FT   MOD_RES     512    512       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     565    565       Phosphoserine.
FT   VARIANT      19     19       R -> K (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041710.
FT   VARIANT      23     23       P -> L (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041711.
FT   VARIANT     193    193       R -> Q (in dbSNP:rs17054374).
FT                                /FTId=VAR_051696.
FT   VARIANT     335    335       R -> W (in LPSA1; shows nearly
FT                                undetectable mutant ITK protein
FT                                consistent with severe protein
FT                                instability).
FT                                /FTId=VAR_063424.
FT   VARIANT     451    451       R -> Q (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041712.
FT   VARIANT     581    581       R -> W (in dbSNP:rs34482255).
FT                                /FTId=VAR_041713.
FT   VARIANT     587    587       V -> I (in dbSNP:rs56005928).
FT                                /FTId=VAR_041714.
FT   CONFLICT    171    172       PE -> GS (in Ref. 6; AA sequence).
FT   CONFLICT    331    331       V -> W (in Ref. 2; AAB28072).
FT   STRAND      127    133
FT   STRAND      148    152
FT   STRAND      171    173
FT   STRAND      175    180
FT   STRAND      187    189
FT   STRAND      197    202
FT   STRAND      205    212
FT   STRAND      214    216
FT   STRAND      218    222
FT   TURN        223    225
FT   STRAND      226    228
FT   STRAND      363    370
FT   STRAND      377    382
FT   TURN        383    385
FT   STRAND      386    392
FT   STRAND      395    398
FT   HELIX       400    412
FT   STRAND      421    425
FT   STRAND      427    430
FT   STRAND      432    436
FT   HELIX       443    448
FT   TURN        449    452
FT   HELIX       456    475
FT   HELIX       485    487
FT   STRAND      488    490
FT   HELIX       492    494
FT   STRAND      496    498
FT   HELIX       527    530
FT   HELIX       537    552
FT   HELIX       564    572
FT   HELIX       585    594
FT   HELIX       599    601
FT   HELIX       605    618
SQ   SEQUENCE   620 AA;  71831 MW;  DAE396BD2309319D CRC64;
     MNNFILLEEQ LIKKSQQKRR TSPSNFKVRF FVLTKASLAY FEDRHGKKRT LKGSIELSRI
     KCVEIVKSDI SIPCHYKYPF QVVHDNYLLY VFAPDRESRQ RWVLALKEET RNNNSLVPKY
     HPNFWMDGKW RCCSQLEKLA TGCAQYDPTK NASKKPLPPT PEDNRRPLWE PEETVVIALY
     DYQTNDPQEL ALRRNEEYCL LDSSEIHWWR VQDRNGHEGY VPSSYLVEKS PNNLETYEWY
     NKSISRDKAE KLLLDTGKEG AFMVRDSRTA GTYTVSVFTK AVVSENNPCI KHYHIKETND
     NPKRYYVAEK YVFDSIPLLI NYHQHNGGGL VTRLRYPVCF GRQKAPVTAG LRYGKWVIDP
     SELTFVQEIG SGQFGLVHLG YWLNKDKVAI KTIREGAMSE EDFIEEAEVM MKLSHPKLVQ
     LYGVCLEQAP ICLVFEFMEH GCLSDYLRTQ RGLFAAETLL GMCLDVCEGM AYLEEACVIH
     RDLAARNCLV GENQVIKVSD FGMTRFVLDD QYTSSTGTKF PVKWASPEVF SFSRYSSKSD
     VWSFGVLMWE VFSEGKIPYE NRSNSEVVED ISTGFRLYKP RLASTHVYQI MNHCWKERPE
     DRPAFSRLLR QLAEIAESGL
//
